Etoposide and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etoposide (etoposide) and Cefdinir (cefdinir). Common drug interactions include hypokalaemia among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Etoposide and Cefdinir. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

On Jul, 10, 2026

19 people who take Etoposide and Cefdinir together, and have interactions are studied.

Etoposide and Cefdinir drug interactions.

What are the common drug interactions of Etoposide and Cefdinir, by gender? *:

female:

Hypokalaemia (low potassium)
Immunoglobulins decreased
Malaise (a feeling of general discomfort or uneasiness)
Myalgia (muscle pain)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia
Weight increased
White blood cell count decreased
Fall
Hypotension (abnormally low blood pressure)

male:

Nausea (feeling of having an urge to vomit)
Cough
Ascites (accumulation of fluid in the abdominal cavity)
Diarrhoea
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Insomnia (sleeplessness)
Abdominal pain
Anaemia (lack of blood)
Aphasia (damage to the parts of the brain that control language)
Aspartate aminotransferase increased

What are the common drug interactions of Etoposide and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain
Acidosis (build-up of carbon dioxide in the blood)
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Aspartate aminotransferase increased
Atelectasis (partial or complete collapse of the lung)
Blood creatinine increased
Cardiac failure

20-29:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Aphasia (damage to the parts of the brain that control language)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood glucose increased
Blood lactate dehydrogenase increased
Blood urea increased
Conjunctival hyperaemia (congestion of conjunctival vessels)
Drug ineffective

30-39:

n/a

40-49:

Fall

50-59:

Muscle atrophy (a decrease in the mass of the muscle)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Myopathy (a muscular disease in which the muscle fibres do not function)
Nausea (feeling of having an urge to vomit)
Abdominal distension
Abdominal pain
Acquired phimosis (inability of the prepuce (foreskin) to be retracted behind the glands penis)
Activities of daily living impaired
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)

60+:

Nausea (feeling of having an urge to vomit)
Cough
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Insomnia (sleeplessness)
Ascites (accumulation of fluid in the abdominal cavity)
Diarrhoea
Hypotension (abnormally low blood pressure)
Urinary tract infection
Febrile neutropenia (fever with reduced white blood cells)
Sputum increased

What are the existing conditions these people have? *

Constipation: 6 people, 31.58%
Pain: 5 people, 26.32%
Fever: 4 people, 21.05%
Productive Cough: 3 people, 15.79%
Joint Pain: 3 people, 15.79%
Lung Cancer - Small Cell (lung cancer): 3 people, 15.79%
Oedema (fluid collection in tissue): 3 people, 15.79%
Nausea (feeling of having an urge to vomit): 3 people, 15.79%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 3 people, 15.79%
B Precursor Type Acute Leukaemia (lymphoid cancer): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously